Eli Lilly To Shift To Commercial Sales Of Its Covid Antibody Drug

 As government orders dry up, the sales of bebtelovimab, which is currently authorized for emergency use, will target states, hospitals, and other health care providers. CNN notes other shifts in government covid policy are happening, with the CDC expected to ease covid guidelines, including for schools.

Eli Lilly & Co. said it plans to begin commercial sales of its Covid-19 monoclonal antibody treatment to states, hospitals and other healthcare providers this month, as the federal government’s supply of the drug is nearly depleted. The move marks a shift away from the way Lilly’s drug and most other Covid-19 treatments and vaccines have been distributed in the U.S. It will likely be the first test of whether the vaccines and treatments would remain accessible if shifted to a commercial market.

https://khn.org/morning-breakout/eli-lilly-to-shift-to-commercial-sales-of-its-covid-antibody-drug/